相关实验视频

Updated: Jan 14, 2026

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

通过mRNA显示,发现了近距离触发的共价-药物合物

Ruixuan Wang¹, Siqi Ran¹, Jiabei Guo¹

¹State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.

Acta pharmaceutica Sinica. B

|October 24, 2025

概括

研究人员开发了一个新的mRNA显示平台,用于发现共价类药物. 这种方法可以快速选大型库,从而产生一种新的Nectin-4向类药物联合体,具有强大的抗癌活性.

科学领域:

在瘤学瘤学.
药用化学医学化学
生物技术是生物技术.

背景情况:

类药物联合体 (PDCs) 提供向的癌症治疗.
共价弹头提高了PDC的效率,但需要复杂的结合.
目前对共价的选方法是低效的.

研究的目的:

开发一个集成的mRNA显示平台,用于共价的发现.
为了能够高效地选大型共价库.
加速用于精密瘤学的新型共价PDCs的识别.

主要方法:

集成的mRNA显示平台与共价核弹头的核糖体合成.
对N-乙-d-phenylalanine和硫酸盐-l-tyrosine的特定场所的整合.
选>10^13共价宏环变体用于Nectin-4向.

主要成果:

通过近距离触发的SuFEx发现了Nectin-4向的CP-N1-N3具有不可逆转的结合 (Ki = 3.58μmol/L).
对MDA-MB-468细胞产生具有强大的细胞毒性 (IC50 ≈ 43 nmol/L) 的共价PDC CP-N1-MMAE.
证明了对共价PDCs的加速发现.

结论:

集成的mRNA显示平台可以有效地发现共价类药物.
这个平台代表了精确的共价药物发现的新范式.
开发的针对PDC的Nectin-4显示出针对性癌症治疗的前景.

关键词:

这是一种共价类.我的灵活性是我的灵活性.硫酸-l-铁素的硫酸-l-铁素的硫酸.一个宏环类.尼克-4的使用方法酸药物联合体交换硫 (VI) 化物在mRNA显示屏上显示mRNA.

更多相关视频

Avidity-based Extracellular Interaction Screening AVEXIS for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions

Avidity-based Extracellular Interaction Screening AVEXIS for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions

Published on: March 5, 2012

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

相关概念视频

Peptide Identification Using Tandem Mass Spectrometry

Peptide Identification Using Tandem Mass Spectrometry

Tandem mass spectrometry, also known as MS/MS or MS2, is an analytical technique that employs two mass analyzers. Essentially it is a series of mass spectrometers that helps isolate a particular biomolecule and then helps study its chemical properties.
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...